Related Experiment Video
Updated: Feb 3, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Microbiome and diabetes: Where are we now?
Natalia G Vallianou1, Theodora Stratigou1, Stylianos Tsagarakis1
1Evangelismos General Hospital, Department of Endocrinology, Diabetes and Metabolism, Athens, Greece.
Gut microbiota alterations (dysbiosis) impact metabolic health, potentially causing obesity and diabetes. This review explores microbiome-based therapies for type 2 diabetes.
Area of Science:
- Microbiology
- Metabolic Disorders
- Gut Microbiome Research
Background:
- Gut microbiota dysbiosis is linked to metabolic disorders like obesity and diabetes.
- Dysbiosis can increase lipopolysaccharide (LPS) levels, promoting inflammation.
- Advanced techniques like metagenomics have improved gut microbiome understanding.
Purpose of the Study:
- To review the relationship between gut microbiota and metabolic disorders.
- To discuss potential therapeutic strategies for type 2 diabetes targeting the gut microbiome.
Main Methods:
- Review of current literature on gut microbiome and metabolic health.
- Analysis of findings from metagenomics, metabolomics, and other relevant studies.
- Discussion of therapeutic interventions including prebiotics, probiotics, and fecal microbiota transplantation.
Main Results:
- Gut microbiota composition influences metabolic activities and body weight.
- Specific microbial metabolites (butyrate, propionate, acetate) show potential in managing obesity and food intake.
- Dysbiosis-associated LPS contributes to inflammatory pathways relevant to metabolic disease.
Conclusions:
- The gut microbiome plays a critical role in metabolic health and disease.
- Targeting the gut microbiome offers promising therapeutic avenues for type 2 diabetes.
- Further research into microbiome-based interventions is warranted.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

